期刊
BLOOD
卷 138, 期 17, 页码 1628-1636出版社
AMER SOC HEMATOLOGY
DOI: 10.1182/blood.2021012153
关键词
-
类别
资金
- National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases [AI33484, AI149213, T32AI118690]
- NIH, National Cancer Institute [CA015704, CA18029]
- NIH, National Heart, Lung, and Blood Institute [HL087690, HL088201, HL094260, HL105914, K24HL093294]
This study found that only the donor ABCB1 gene variant was associated with CMV reactivation after allogeneic hematopoietic cell transplantation. Other genetic variants previously linked to CMV phenotypes did not significantly alter the risk for CMV reactivation or disease post-transplant.
Human cytomegalovirus (CMV) reactivation is a frequent complication of allogeneic hematopoietic cell transplantation (HCT). Despite routine screening for CMV reactivation and early antiviral treatment, the rates of CMV-related complications after HCT remain high. Genetic variants in both the donor and recipient have been associated with the risk of CMV reactivation and disease after HCT, but these associations have not been validated, and their clinical importance remains unclear. In this study, we assessed 117 candidate variants previously associated with CMV-related phenotypes for association with CMV reactivation and disease in a cohort of 2169 CMV-seropositive HCT recipients. We also carried out a genome-wide association study (GWAS) for CMV reactivation and disease in the same cohort. Both analyses used a prespecified discovery and replication approach to control the risk of false-positive results. Among the 117 candidate variants, our analysis implicates only the donor ABCB1 rs1045642 genotype as a risk factor for CMV reactivation. This synonymous variant in P-glycoprotein may influence the risk of CMV reactivation by altering the efflux of cyclosporine and tacrolimus from donor lymphocytes. In the GWAS analysis, the donor CDC42EP3 rs11686168 genotype approached the significance threshold for association with CMV reactivation, although we could not identify a mechanism to explain this association. The results of this study suggest that most genomic variants previously associated with CMV phenotypes do not significantly alter the risk for CMV reactivation or disease after HCT.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据